Alectinib for treating patients with metastatic ALK-positive NSCLC: systematic review and network metanalysis
{{output}}
Aim: To compare the efficacy and safety of alectinib with other ALK inhibitors in treating patients with metastatic or locally advanced ALK-positive NSCLC. Method... ...
